IP Library › Granted Patent US 12,736,540
Granted Patent B2
US 12,736,540 · App. 18/967,540 · Granted Sep 15, 2026

Methods for identifying modifications of a polypeptide

Inventors: Parag Mallick (San Mateo, CA); Jarrett D. Egertson (Rancho Palos Verdes, CA); Gregory Kapp (San Carlos, CA)
Assignee: NAUTILUS SUBSIDIARY, INC.
G01N33/6845
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,736,540
App. No.
18/967,540
Granted
Sep 15, 2026
Kind
B2
Abstract

Systems and methods for obtaining qualitative or quantitative measurements of proteoforms of polypeptides are described. The described methods include measurements of affinity reagent binding on single-molecule polypeptide arrays to distinguish between polypeptide isoforms. The described methods may provide high resolution quantitative comparisons of proteoforms with very low copy numbers.

Claims (26)

1 . A method for comparing proteoforms of a first type of polypeptide in a plurality of samples, comprising:

providing the first type of polypeptides on an array from a first sample, wherein individual polypeptide molecules of the first type of polypeptides are located at an individually observable address on the array;

sequentially contacting the array with a plurality of different types of affinity reagents, wherein each of the plurality of different types of affinity reagents has binding specificity for a different modification to the first type of polypeptide;

characterizing proteoforms of the first type of polypeptides in the first sample based upon the types of different affinity reagents that bind or do not bind to the individual polypeptides on the array;

providing the first type of polypeptides on an array from a second sample, wherein individual polypeptide molecules of the first type of polypeptides are located at an individually observable address on the array;

sequentially contacting the array with a plurality of different types of affinity reagents, wherein each of the plurality of different types of affinity reagents has binding specificity for a different modification to the first type of polypeptide;

characterizing proteoforms of the first type of polypeptides in the second sample based upon the types of different affinity reagents that bind or do not bind to the individual polypeptides on the array; and

comparing proteoforms of the first type of polypeptide in the first sample to proteoforms of the first type of polypeptide in the second sample.

2 . The method of claim 1 , wherein characterizing the proteoforms of the first type of polypeptide in the first and second samples comprises characterizing patterns of modifications in each of the plurality of individual polypeptides on the array in each of the providing steps.

3 . The method of claim 1 , wherein characterizing proteoforms in the first and second samples comprises quantifying different patterns of modifications to the polypeptides in the first and second samples from quantification of the different patterns of modifications of polypeptides on the array.

4 . The method of claim 2 , wherein the modifications comprise post translational modifications.

5 . The method of claim 4 , wherein the modifications comprise a modification at one or more of a plurality of amino acid residues in the polypeptides, wherein such modifications are independently selected from myristoylation, palmitoylation, isoprenylation, prenylation, farnesylation, geranylgeranylation, lipoylation, flavin moiety attachment, Heme C attachment, phosphopantetheinylation, retinylidene Schiff base formation, dipthamide formation, ethanolamine phosphoglycerol attachment, hypusine, beta-Lysine addition, acylation, acetylation, deacetylation, formylation, alkylation, methylation, C-terminal amidation, arginylation, polyglutamylation, polyglyclyation, butyrylation, gamma-carboxylation, glycosylation, glycation, polysialylation, malonylation, hydroxylation, iodination, nucleotide addition, phosphoate ester formation, phosphoramidate formation, phosphorylation, adenylylation, uridylylation, propionylation, pyrolglutamate formation, S-glutathionylation, S-nitrosylation, S-sulfenylation, S-sulfinylation, S-sulfonylation, succinylation, sulfation, glycation, carbamylation, carbonylation, isopeptide bond formation, biotinylation, carbamylation, oxidation, reduction, pegylation, ISGylation, SUMOylation, ubiquitination, neddylation, pupylation, citrullination, deamidation, elminylation, disulfide bridge formation, proteolytic cleavage, isoaspartate formation, and racemization.

6 . The method of claim 2 , wherein the modifications comprise phosphorylation at one or more amino acid residues in the polypeptides.

7 . The method of claim 6 , wherein the modifications comprise phosphorylation at one or more of a plurality of amino acid residues in the polypeptide, and wherein each of a plurality of the affinity reagents has a binding specificity for a polypeptide that comprises a phosphorylation at a different amino acid residue or set of amino acid residues in the polypeptide.

8 . The method of claim 7 , further comprising characterizing one or more patterns of phosphorylated amino acid residues in the individual polypeptides on the array.

9 . The method of claim 8 , further comprising determining a quantity of different patterns of phosphorylated amino acid residues in the sample from the quantity of different patterns of phosphorylated amino acid residues in the polypeptides on the array.

10 . The method of claim 2 , wherein the modification comprises a splice variation to the type of polypeptide, and each of a plurality of the affinity reagents have a binding specificity to different individual polypeptides of the first type of polypeptide having different splice variations.

11 . The method of claim 5 , comprising, following identification of one or more modifications on the polypeptides on the array, treating the polypeptides on the array to remove one or more of the modifications, and repeating the contacting and identify steps to identify polypeptides on the array having the modifications removed.

12 . The method of claim 11 , wherein one or more of the modifications comprise a phosphorylated amino acid residue in the polypeptides, and the treating step comprises contacting the polypeptides with a phosphatase enzyme.

13 . The method of claim 1 , wherein the contacting step comprises sequentially contacting the polypeptides on the array with at least three different affinity reagents.

14 . The method of claim 1 , wherein the contacting step comprises sequentially contacting the polypeptides on the array with at least four different affinity reagents.

15 . The method of claim 1 , wherein the contacting step comprises sequentially contacting the polypeptides on the array with at least six different affinity reagents.

16 . The method of claim 1 , wherein the contacting step comprises sequentially contacting the polypeptides on the array with at least eight different affinity reagents.

17 . The method of claim 1 , wherein at least two different affinity reagents are contacted with the array simultaneously.

18 . The method of claim 1 , further comprising the step of identifying individual locations on the array occupied by the first type of polypeptides.

19 . The method of claim 18 , wherein the step of identifying individual locations on the array occupied by the first type of polypeptides comprises sequentially contacting the polypeptides on the array with a plurality of different affinity reagents, each different affinity reagent having affinity for a different epitope of amino acids, and identifying the polypeptides based upon a pattern of binding of the different affinity reagents to the epitopes in the polypeptides on the array.

Assignments (2)
CHANGE OF NAME Recorded May 19, 2026
From: NAUTILUS BIOTECHNOLOGY, INC.
To: NAUTILUS SUBSIDIARY, INC.
Reel/Frame 075585/0401 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 13, 2026
From: MALLICK, PARAG; EGERTSON, JARRETT D.; KAPP, GREGORY
To: NAUTILUS BIOTECHNOLOGY, INC.
Reel/Frame 075573/0615 →
Continuity (5)
Continuation 18783234 · Jul 24, 2024
Continuation 17579576 · Jan 19, 2022
Provisional Application 63193486 · May 26, 2021
Provisional Application 63139739 · Jan 20, 2021
Related Publication 20250180578A1 · Jun 5, 2025
References Cited (58)
US 7306904B2 · Landegren et al. · 2007 [cited by applicant]
US 7351528B2 · Landegren · 2008 [cited by applicant]
US 7855054B2 · Schneider et al. · 2010 [cited by applicant]
US 7964356B2 · Zichi et al. · 2011 [cited by applicant]
US 8013134B2 · Fredriksson · 2011 [cited by applicant]
US 8222047B2 · Duffy et al. · 2012 [cited by applicant]
US 8236574B2 · Duffy et al. · 2012 [cited by applicant]
US 8268554B2 · Schallmeiner · 2012 [cited by applicant]
US 8404830B2 · Zichi et al. · 2013 [cited by applicant]
US 8415171B2 · Rissin et al. · 2013 [cited by applicant]
US 8945830B2 · Heil et al. · 2015 [cited by applicant]
US 8975026B2 · Zichi et al. · 2015 [cited by applicant]
US 8975388B2 · Zichi et al. · 2015 [cited by applicant]
US 9163056B2 · Rohloff et al. · 2015 [cited by applicant]
US 9395359B2 · Walt et al. · 2016 [cited by applicant]
US 9404919B2 · Schneider et al. · 2016 [cited by applicant]
US 9625469B2 · Marcotte et al. · 2017 [cited by applicant]
US 9678068B2 · Duffy et al. · 2017 [cited by applicant]
US 9777315B2 · Fredriksson et al. · 2017 [cited by applicant]
US 9926566B2 · Ochsner et al. · 2018 [cited by applicant]
US 9938314B2 · Rohloff et al. · 2018 [cited by applicant]
US 10221207B2 · Rohloff et al. · 2019 [cited by applicant]
US 10221421B2 · Jarvis et al. · 2019 [cited by applicant]
US 10239908B2 · Rohloff et al. · 2019 [cited by applicant]
US 10316321B2 · Zichi et al. · 2019 [cited by applicant]
US 10392621B2 · Ochsner et al. · 2019 [cited by applicant]
US 10473654B1 · Mallick · 2019 [cited by applicant]
US 10545153B2 · Marcotte et al. · 2020 [cited by applicant]
US 11203612B2 · Gremyachinskiy et al. · 2021 [cited by applicant]
US 20070224628A1 · Gordon · 2007 [cited by examiner]
US 20190145982A1 · Chee et al. · 2019 [cited by applicant]
US 20200082914A1 · Patel et al. · 2020 [cited by applicant]
US 20200286584A9 · Patel et al. · 2020 [cited by applicant]
US 20200318101A1 · Mallick et al. · 2020 [cited by applicant]
US 20200348307A1 · Beierle et al. · 2020 [cited by applicant]
US 20200348308A1 · Chee et al. · 2020 [cited by applicant]
US 20210239705A1 · Mallick · 2021 [cited by applicant]
US 20210390705A1 · Egertson et al. · 2021 [cited by applicant]
EP 1491894 · 2004 [cited by applicant]
WO WO2019236749 · 2019 [cited by applicant]
WO WO2020106889 · 2020 [cited by applicant]
WO WO2020223368 · 2020 [cited by applicant]
WO WO2021087402 · 2021 [cited by applicant]
Aebersold et al., “How many human proteoforms are there?”, Nat Chem Biol vol. 14:206-214 (2018). [cited by applicant]
Alfaro et al., “The emerging landscape of single-molecule protein sequencing technologies”, Nature Publishing Group US, vol. 18(6):604-617 (2021). [cited by applicant]
Anderson et al., “The human plasma proteome: history, character, and diagnostic prospetcs”, Molecular &Cellular Proteomics: MCP, vol. 1(11):845-867 (2002). [cited by applicant]
Chang, “A novel Edman-type degradation: direct formation of the thiohydantoin ring in alkaline solution by reaction of Edman-type reagents with N-monomethyl amino acids”, FEBS Letters 91.1:63-68 (1978). [cited by applicant]
Egertson et al., “A theoretical framework for proteome-scale single-molecule protein identification using multi-affinity protein binding reagents”, BioRxiv (2021), DOI: 10.1101/2021.10-11.463967. [cited by applicant]
Ho et al., “Unification of protein abundance datasets yields a quantitative [cited by applicant]
Kim et al., “Direct profiling the post-translational modification codes of a single protein immobilized on a surface using cu-free click chemistry”, ACS Central Science, vol. 4(5):614-623 (2018). [cited by applicant]
Nielsen et al., “Multiplexed sandwich assays in microarray format”, Journal of Immunological Methods, vol. 290:107-120 (2004). [cited by applicant]
Nielsen et al., “Profiling receptor tyrosine kinase activation by using Ab microarrays”, PNAS, vol. 100(16):9330-9335 (2003). [cited by applicant]
Smith et al., “Proteoform: a single term describing protein complexity”, Nature Methods vol. 10(3):186-187 (2013). [cited by applicant]
Swaminathan et al., “Highly parallel single-molecule identification of proteins in septomole-scale mixtures”, Nat Biotechnol. vol. 36:1076-1082 (2018). [cited by applicant]
Walker, “The dansyl method for identifying N-terminal amino acids”, Methods in Molecular Biology, vol. 1:203-212 (1984). [cited by applicant]
Winiewski et al., “A proteomic ruler for protein copy number and concentration estimation without spike-in standards”, Molecular & Cellular Proteomics, vol. 13:10.1074 (2014). [cited by applicant]
International Search Report and Written Opinion in Application No. PCT/US2022/013017, dated Jul. 18, 2022. [cited by applicant]
Budamagunta, et al., “Large-scale single-molecule analysis of tau proteoforms” Jul. 21, 2025. https://doi.org/10.1101/2025.06.26.660445. [cited by applicant]